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In order to study the prevalence of Group A beta-hemolytic Streptococcus (GABHS)
pharyngotonsillitis in our pediatric population and to compare different sampling methods of
GABHS detection, oropharyngeal swabs from 50 children with acute pharyngotonsillitis, between
1 and 12 years old, were used simultaneously for culture, molecular assay and rapid GABHS
antigen detection tests. All children were clinically examined at the Division of Pediatric
Otorhinolaryngology of the Federal University of São Paulo. Diagnostic criteria were based on
signs and symptoms, including sore throat, fever and oropharyngeal purulent secretion. Children
that had been treated with antibiotics were excluded. Overall, combining the three methods, the
prevalence of GABHS was 34%. GABHS was diagnosed in 30% of the bacterial cultures, in
25% of the samples tested with the molecular nucleic acid hybridization method and in 26% of
the cases tested with the rapid antigen detection test. There was no significant difference between
these three methods.
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Pharyngotonsillitis is one of the most common
respiratory diseases in the community, particularly during
childhood. Approximately 28% to 40% of these
infections are estimated to be caused by Group A beta-
hemolytic Streptococcus (GABHS), which is
considered the most important etiological pathogen in
terms of sequelae and complications [1]. Since
streptococcal pharyngotonsillitis can lead to rheumatic
disease and its sequelae, and to suppurative
complications, it is a potentially serious medical
problem, and adequate treatment is imperative.
Despite many attempts to clinically differentiate
Streptococcal pharyngotonsillitis from viral infections,
so far no method has proven to be reliable [2].  Due to
the lack of an adequate clinical basis to diagnose
GABHS pharyngotonsillitis, it is important to find an
easy, practical and cost-effective way to provide such
a differentiation.
During the last fifty years, bacterial culture has been
the main technique used to diagnose GABHS. In 1980,
the Center for Disease Control (CDC), estimated that
28 to 36 million throat cultures were performed each
year in the USA. Throat culture is still considered the
“gold standard” method for GABHS detection, giving
positive results in about 90% to 99% of the cases [3].
The use of rapid tests to detect GABHS directly
from throat swabs has become very popular in many
countries. Most of these tests employ latex
agglutination or enzyme immunoassay methods to
detect the Group A carbohydrate antigen of
Streptococcus pyogenes [4-7].
Although molecular hybridization tests are not as
popular, they have been shown to have a high level of
specificity and sensitivity [8].
To determine the prevalence of GABHS pharyngeal
infection , and to find the best way to make this
diagnosis, we evaluated children with acute
pharyngotonsillitis and compared three different
methods of GABHS detection from throat swabs:
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culture in blood-agar, rapid GABHS detection test, and
the GABHS nucleic acid hybridization test.
Materials and Methods
Fifty children with acute pharyngotonsillitis, between
1 and 12 years old were evaluated at the Division of
Pediatric Otorhinolaryngology – Federal University of
São Paulo, Brazil, from 1998-2001. Diagnostic criteria
and selection were based on clinical signs and
symptoms, including sore throat, fever, cervical
lymphadenitis and purulent oropharyngeal secretions.
Parents or legal guardians signed an informed consent.
Oropharyngeal swabs were taken simultaneously
for the three detection methods:
1. Culture. Oropharyngeal samples were collected
with  “Starswab” (Laborclin®), immediately
transported to the Microbiology Laboratory and spread
on a 5% blood agar plate (Columbia agar-base,
Oxoid), followed by 18-24 hours incubation at 36oC
in a 5% CO2 environment. Biochemical, anti-sera
agglutination and optoquin/bacitracin sensitivity tests
were performed to identify the GABHS.
2. Samples for the rapid detection test (Test Pack®
Strep A – Abbott) were collected in alginated swabs.
The tests were all performed “in loco”, according to
the method provided by the manufacturer.  The rapid
detection test (Abbott) is based on the detection of the
GABHS antigen through an ELISA antigen-AC
agglutination reaction.
3.  Identification of GABHS by the nucleic acid
hybridization test (GEN-PROBE
INCORPORATED, San Diego, California –
AccuPACE GROUP A STREPTOCOCCUS
IDENTIFICATION TEST) following the
manufacturer’s specifications. Alginated swabs were
inoculated into Tryptic Soy Broth, and incubated at
36oC for 18 to 24 hours, in an environment enriched
with CO2.  Results were obtained   by
chemiluminescence. Values of 20,000 relative
luminescence units (RLU) or higher were considered
positive; under 15,000 RLU was considered negative,
and between 15,000 and 19,999 was weakly positive.
Results
The prevalence of Streptococcus pyogenes was
34% (17 cases) with the combination of the three
methods. GABHS was detected in 30% (15 cases) of
the cultures, 26% (12 cases) by molecular assay tests,
and 26% (13 cases) by the rapid identification test
(Table 1).
Considering the culture result as a “gold standard”
parameter, the rapid test gave a sensitivity of 73%
(positive cases compared to the total positive cases
obtained by culture), and a specificity of 94% (negative
results compared to the total number of negative culture
cases), a positive predictive value of 85%, and a
negative predictive value of 88% (Table 2).
Molecular tests (acid nucleic hybridization tests)
were performed on 47 samples. Concordance of
results by using the different methods occurred in 76%
of the cases. In four samples  (8.5%), the molecular
assay was positive, while the culture was negative.
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Table 1. Frequency of Group A beta-hemolytic
Streptococcus according to the three detection
methods
Table 2. Diagnostic value of the rapid test
Culture
Positive Negative
Rapid test Positive 11 02
Negative 04 32
Results Rapid test Culture Gene probe
(n=49) (n=50) (n=47)
N % N % N %
Positive 13 26 15 30 12 25
Negative 36 73 35 70 35 74
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Discussion
Streptococcal pharyngotonsillitis has been a matter
of medical concern over the years, particularly because
of its potential for causing serious problems, such as
rheumatic fever and suppurative complications. The
prevalence of acute pharyngotonsillitis caused by
GABHS is approximately 28% to 40% worldwide;
most are known to be susceptible to penicillin. This
percentage also varies from region to region [1].
The prevalence of GABHS in São Paulo, Brazil
appears to be similar to the international figures, since
overall, GABHS was found in 34% of the children.
These GABHS isolates were also all susceptible to
penicillin (data not shown).
The unreliability of the diagnosis based on clinical
grounds, has been one of the limiting factors to an
adequate management of this disease, especially in
developing countries where the rapid detecting tests
or even bacterial cultures are not always available. A
number of commercial test kits are current available in
many countries for the rapid diagnosis of group A
streptococcal pharyngotonsillitis, and the most recent
are immunoassay-based. Their specificity reaches
around 89-99%, and the sensitivity varies between 77
and 98%, considering bacterial culture as a “gold
standard” parameter [5]. Most of these tests can be
performed “in loco”, and the results are available in
approximately 15 minutes.
In countries where rapid detection tests are routinely
used, a controversy exists regarding whether or not a
confirmatory culture is necessary when the results are
negative. Although most the doctors do not usually
follow this procedure, most of the medical societies
have recommended backup cultures [9]. The use of a
rapid detection test, plus a bacterial culture for the
negative results, is currently considered the most
effective clinical strategy, increasing the marginal costs
only slightly (it increases the initial costs, but lowers the
global cost when considering the prevention of
complications of the non-treated rapid test undetected
cases) [10].
Combining these three methods, the prevalence of
Streptococcus pyogenes in this study was slightly higher
than in our previous study, where bacterial culture was
the method used. In our study, made in 1996, 18% of
the cultures from 44 children with oropharyngeal
infection had GABHS  [11].
Although in our current study the molecular assay
method was able to detect GABHS in some cases with
negative culture results, it was time consuming and
expensive. Pokorski et al. (1994) [8], in a study of
767 patients with pharyngitis, the sensitivity of the
molecular assay method was 85.7% and  the specificity
was, 97.8%, compared to 96.7% sensitivity and 100%
specificity with bacterial cultures.
Given the international diversity of social and
economic conditions, and even the differences of
specificity and sensitivity of GABHS detection methods
found in several studies, many options of GABHS
pharyngotonsillitis management could be considered.
According to a cost-benefit analysis, treating all the
patients, without a previous culture or test would
prevent 90% of the potential complications,
decreasing the overall costs [10]. On the other hand,
there would be more side effects from antibiotics,
and their use would be unnecessary in most cases.
Whenever an isolated rapid detection test is chosen
(with no back up culture), cost-benefit advantages
may be significant if the test sensitivity and the follow-
up rate are high [10].
Although several studies have shown that the rapid
test, applied alone, does not have sufficient sensitivity
to eliminate the need for cultures [7], some researchers
have demonstrated that the more recently available
rapid tests can be more sensitive than bacterial culture,
particularly the immunoassay-based tests, which can
give results in a few minutes [6].
Interestingly, bacterial culture has been considered
by many as the “gold standard” method of GABHS
detection, however according to recent studies, this
would be a high cost choice in relation to its
effectiveness [10].
Overall, we found the prevalence of GABHS in our
population to be similar to international data, around
30%. We also found no significant differences in
sensitivity or specificity when comparing the rapid test
detection with bacterial culture results.
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Because of the higher costs and the considerable
time and labor involved in molecular assay method,
we would not recommend it for routine use.
Despite the considerable economic and social
diversity existing in our country, where often the rapid
test or even bacterial culture techniques are not
available, which may lead doctors to diverse
management options, including treating the patient
based only on clinical assumptions, we believe that
objective diagnostic procedures, such as the rapid test
or bacterial cultures, should be stimulated.
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